The Bancorp
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 weeks.
- Its last 9 Sell calls were actually followed by a +16% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -30.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 8.9% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation A
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 7.8x | Better than 89% |
| Forward P/E | 7.3x | Better than 92% |
| Price / Sales | 2.9x | Better than 44% |
| P/E vs own 5-yr range | 1st pctl | Better than 98% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 25.7% | Better than 87% |
| Net income CAGR (3Y) | 20.6% | Better than 73% |
| Free cash flow CAGR (3Y) | 30.7% | Better than 75% |
Profitability A+
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 32.4% | Better than 92% |
| Return on equity | 30.8% | Better than 88% |
Momentum D+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -34.4% | Better than 14% |
| 6-month return | -20.3% | Better than 27% |
| 12-month return (ex latest month) | -18.0% | Better than 16% |
| Distance below 52-week high | 39.6% | Better than 29% |
Financial Health A-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 2.4% | Better than 87% |
| Free cash flow / net income | 112.1% | Better than 46% |
Analyst View A-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 43.6% | Better than 62% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 44.26
- Open
- 44.12
- Day range
- 44.00 - 45.64
- Avg price
- 44.34
- Volume
- 556.78K
- Turnover
- 24.68M
- Turnover ratei
- 1.49%
- Volume ratioi
- 1.04
- Amplitudei
- 3.71%
- 52-week rangei
- 43.54 - 73.02
Valuation
- P/Ei
- 8.96
- P/E (TTM)i
- 7.78
- P/Bi
- 2.60
- EPSi
- 4.92
- Book value / shi
- 16.95
- Net profit
- 196.46M
- Net assets
- 676.78M
Share structure
- Market cap
- 1.76B
- Float capi
- 1.65B
- Shares out
- 39.93M
- Float sharesi
- 37.45M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
39.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-9.06M net over the window
Short interest
- Shares short
- 3.62M
- % of floati
- 8.88%
- Days to coveri
- 7.95
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of The Bancorp (TBBK)?
The Bancorp last traded at 44.09. This page shows a periodic quote snapshot. Check the displayed quote time.
What is The Bancorp's market cap?
About 1.76B.
What is the P/E ratio of The Bancorp?
The trailing twelve-month P/E is 7.78, below its own 5-year average of 12.62 — toward the bottom of its historical range (1.12% percentile). See the Valuation tab for the full history.
Does The Bancorp pay a dividend?
The Bancorp does not currently pay a regular dividend.
Is The Bancorp a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 63.33, which implies 43.6% upside from the current price. This is not investment advice.
What is The Bancorp's StockVane Quant Rating?
The StockVane Momentum strategy currently rates The Bancorp a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
The Bancorp discussion 0 comments